Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component

Substrate Specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM Efflux Pumps in <i>Pseudomonas aeruginosa</i>

Nobuhisa Masuda, Eiko Sakagawa, Satoshi Ohya et al. · Antimicrobial Agents and Chemotherapy · 2000 · 685 citations · Full text

Life Sciences, Microbiology, Antimicrobial Resistance +13

Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and <i>In Vitro</i> - <i>In Vivo</i> Correlation Data for Antifungal Drug Combinations against <i>Aspergillus fumigatus</i>

Joseph Meletiadis, Spyros Pournaras, Emmanuel Roilides et al. · Antimicrobial Agents and Chemotherapy · 2009 · 332 citations · Full text

Medicine, Pharmacology, Biopharmaceutics +16

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

George G. Zhanel, Mel DeCorby, Nancy M. Laing et al. · Antimicrobial Agents and Chemotherapy · 2008 · 271 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

The MexJK Efflux Pump of <i>Pseudomonas aeruginosa</i> Requires OprM for Antibiotic Efflux but Not for Efflux of Triclosan

Rungtip Chuanchuen, Craig T. Narasaki, Herbert P. Schweizer · Journal of Bacteriology · 2002 · 232 citations · Full text

Life Sciences, Genetics, Microbiology +17

Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide

Robert L. Danner, Keith A. Joiner, Marc Rubin et al. · Antimicrobial Agents and Chemotherapy · 1989 · 162 citations

Veterinary Medicine, Pharmacology, Toxicology +16